Streetbeat News

Products Services

GSK

UBS released a note stating that the ACIP Working Group recommends a universal RSV vaccine for individuals aged 75 and older from GSK. However, there is no endorsement for ages 50-59 due to limited data, and the recommendation for ages 60-74 is only for those 'at risk'.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:38 pm

PFE

Pfizer reports a 15% decrease in patient enrollment in its Phase 3 ulcerative colitis trial, with enrollment dropping from 912 to 772 patients. The trial is active but not recruiting, and the primary completion date has been revised to July 20, 2026.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:22 pm

NVO

Novo Nordisk has halted the OCEDURENONE Clarion-CKD trial and recognized an impairment loss.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:21 pm

AMZN

ETSY

FXI

PDD

SHOP

Amazon is planning to launch a new discount section similar to Temu, with direct shipping from China. This move could impact other e-commerce platforms and related ETFs.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:10 pm

BTCUSD

ETHUSD

Veteran trader Flood Capital predicts new all-time highs for Bitcoin and Ethereum, citing market dynamics, ETF impacts, and improving sentiment. The trader highlights the influence of Bitcoin ETFs and the potential for Ethereum ETFs to drive market growth.

Portfolio Pulse from Khyathi Dalal

June 26, 2024 | 5:07 pm

INTC

Intel's Xeon processors are being used to accelerate GenAI workloads in collaboration with Aible, potentially enhancing performance and efficiency in AI applications.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 5:04 pm

SVRA

Savara shares are trading lower after initially rising on the results of their Phase 3 IMPALA-2 clinical trial.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 4:56 pm

CVS

GSK

MRNA

PFE

Moderna's stock is trading lower due to concerns over the declining efficacy of its RSV vaccine compared to competitors GSK and Pfizer. The CDC's Advisory Committee on Immunization Practice is set to review vaccine recommendations, and Moderna's data shows a significant drop in efficacy over time. GSK and Pfizer's vaccines have shown better long-term efficacy, with GSK securing a larger market share and Pfizer winning a major contract in the U.K.

Portfolio Pulse from Vandana Singh

June 26, 2024 | 4:54 pm

META

Meta Platforms Inc. (NASDAQ:META) faces backlash after users discovered changes to political content settings on Instagram and Threads. The settings, intended to limit political content recommendations, were found to reset upon app closure, causing user frustration. Meta acknowledged the issue and is working on a fix.

Portfolio Pulse from Franca Quarneti

June 26, 2024 | 4:53 pm

EIPX

KEAT

TTE

TotalEnergies SE (NYSE:TTE) has acquired a 60% stake in Block STP02 in São Tomé and Príncipe, expanding its exploration efforts in Africa. The company's shares are trading lower, down 2.10% at $66.22. Investors can gain exposure to TTE via ETFs such as First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF (ARCA: EIPX) and Keating Active ETF (NASDAQ: KEAT).

Portfolio Pulse from Lekha Gupta

June 26, 2024 | 4:50 pm